你即將離開本站

並前往https://impulse-dynamics.com/fda-indications-patient-selection/

FDA Indications & Patient Selection - Impulse Dynamics

FDA Indications & Patient Selection · Approximately 70% of patients with NYHA Class III heart failure are not indicated for cardiac resynchronization therapy.

確定！ 回上一頁

查詢 「Indications」的人也找了：

  1. indications中文
    2.
  2. indication醫學中文
    3.
  3. indications意思
    4.
  4. indication適應症
    5.
  5. indication用法
    6.
  6. Indication
    7.
  7. No indication
    8.
  8. Dosage indication
    9.